Akizawa T - Search Results

1

Higher hemoglobin levels using darbepoetin alfa and kidney outcomes in advanced chronic kidney disease without diabetes: a prespecified secondary analysis of the PREDICT trial.

Maruyama S, Kurasawa S, Hayashi T, Nangaku M, Narita I, Hirakata H, Tanabe K, Morita S, Tsubakihara Y, Imai E, Akizawa T; PREDICT Investigators. Maruyama S, et al. Among authors: akizawa t. Clin Exp Nephrol. 2023 Sep;27(9):757-766. doi: 10.1007/s10157-023-02362-w. Epub 2023 Jun 8. Clin Exp Nephrol. 2023. PMID: 37289335 Free PMC article. Clinical Trial.

2

Effects of 1,25-dihydroxy-22-oxavitamin D(3) on parathyroid gland function in haemodialysis patients with secondary hyperparathyroidism.

Kinugasa E, Akizawa T, Takahashi J, Nabeshima K, Ogata H, Nakayama F, Ideura T. Kinugasa E, et al. Among authors: akizawa t. Nephrol Dial Transplant. 2002;17 Suppl 10:20-7. doi: 10.1093/ndt/17.suppl_10.20. Nephrol Dial Transplant. 2002. PMID: 12386265 Clinical Trial.

3

Management of secondary hyperparathyroidism of dialysis patients.

Akizawa T, Kamimura M, Mizobuchi M, Shiizaki K, Sumikado S, Sakaguchi T, Negi S, Ogata H, Kinugasa E. Akizawa T, et al. Nephrology (Carlton). 2003 Oct;8 Suppl:S53-7. doi: 10.1046/j.1440-1797.8.s.9.x. Nephrology (Carlton). 2003. PMID: 15012693 Review.

4

Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency.

Mizobuchi M, Hatamura I, Ogata H, Saji F, Uda S, Shiizaki K, Sakaguchi T, Negi S, Kinugasa E, Koshikawa S, Akizawa T. Mizobuchi M, et al. Among authors: akizawa t. J Am Soc Nephrol. 2004 Oct;15(10):2579-87. doi: 10.1097/01.ASN.0000141016.20133.33. J Am Soc Nephrol. 2004. PMID: 15466262

5

2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.

Gejyo F, Saito A, Akizawa T, Akiba T, Sakai T, Suzuki M, Nishi S, Tsubakihara Y, Hirakata H, Bessho M; Japanese Society for Dialysis Therapy. Gejyo F, et al. Among authors: akizawa t. Ther Apher Dial. 2004 Dec;8(6):443-59. doi: 10.1111/j.1774-9987.2004.00199.x. Ther Apher Dial. 2004. PMID: 15663544

6

Study design and methods for a clinical trial of an oral carbonaceous adsorbent used to prevent the progression of chronic kidney disease (CAP-KD).

Morita S, Fukuhara S, Akizawa T, Asano Y, Kurokawa K. Morita S, et al. Among authors: akizawa t. Clin Exp Nephrol. 2005 Sep;9(3):219-27. doi: 10.1007/s10157-005-0358-7. Clin Exp Nephrol. 2005. PMID: 16189630

7

Prognostic factors for a composite end-point of renal outcomes in patients with chronic kidney disease.

Morita S, Fukuhara S, Akizawa T, Asano Y, Koshikawa S, Koide K, Kurokawa K. Morita S, et al. Among authors: akizawa t. Ther Apher Dial. 2006 Feb;10(1):72-7. doi: 10.1111/j.1744-9987.2006.00307.x. Ther Apher Dial. 2006. PMID: 16556140

8

[Vitamin D metabolism and chronic kidney disease].

Honda H, Sanada D, Akizawa T. Honda H, et al. Among authors: akizawa t. Clin Calcium. 2006 Jul;16(7):1143-46. Clin Calcium. 2006. PMID: 16816474 Review. Japanese.

9

[Kidney as a regulating organ for calcium and phosphate homeostasis].

Honda H, Hosaka N, Akizawa T. Honda H, et al. Among authors: akizawa t. Clin Calcium. 2007 May;17(5):654-8. Clin Calcium. 2007. PMID: 17470992 Review. Japanese.

10

[Chronic kidney diseases and other diseases. 2. Kidney failure].

Honda H, Nagai H, Akizawa T. Honda H, et al. Among authors: akizawa t. Nihon Naika Gakkai Zasshi. 2007 May 10;96(5):894-8. doi: 10.2169/naika.96.894. Nihon Naika Gakkai Zasshi. 2007. PMID: 17564079 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

590 results

Search Page

Filters